Mounjaro vs Insulin: Key UK Differences | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro vs Insulin UK Price £124.99

Discover the cheapest UK price for Mounjaro from £124.99 with £20 off your first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Mounjaro vs Insulin: Understanding the Differences

Published on: June 03, 2026

Many UK patients ask about mounjaro vs insulin uk differences when exploring diabetes and weight management options. Mounjaro (tirzepatide) is not insulin — it's a dual GIP/GLP-1 receptor agonist that works by stimulating your body's own insulin production, whilst insulin replacement therapy directly supplements the hormone your pancreas cannot produce in sufficient quantities.

What Is Mounjaro and How Does It Differ from Insulin?

Mounjaro contains tirzepatide, the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA in the UK [1]. Unlike insulin, which directly replaces the hormone your pancreas produces, Mounjaro works by enhancing your body's natural insulin secretion in response to food intake. This glucose-dependent mechanism means Mounjaro only triggers insulin release when blood sugar levels are elevated, significantly reducing hypoglycaemia risk compared to exogenous insulin therapy.

Insulin therapy involves injecting synthetic insulin to manage blood glucose levels directly. It's essential for people with type 1 diabetes, whose pancreas produces little or no insulin, and often necessary for advanced type 2 diabetes when the pancreas can no longer produce adequate amounts [2]. Mounjaro, by contrast, is only suitable for type 2 diabetes patients who retain some pancreatic function, as it requires the body's ability to produce insulin in response to the medication's signalling.

Mechanisms of Action: Mounjaro vs Insulin UK Differences

Insulin works immediately to lower blood glucose by facilitating cellular glucose uptake and suppressing hepatic glucose production. It's a hormone replacement that addresses the fundamental deficit in diabetes — insufficient insulin to manage blood sugar effectively. Dosing requires careful titration based on blood glucose monitoring, carbohydrate intake, and physical activity levels.

Mounjaro operates through a fundamentally different pathway. By activating both GIP and GLP-1 receptors, tirzepatide enhances glucose-dependent insulin secretion, suppresses inappropriately elevated glucagon, slows gastric emptying, and reduces appetite through central nervous system pathways [1]. In the SURPASS-2 trial, patients taking the 15mg dose achieved an average HbA1c reduction of 2.46% compared to 1.86% with semaglutide, demonstrating superior glycaemic control through this dual-receptor mechanism [3].

Glucose-Dependent vs Direct Action

The glucose-dependent nature of Mounjaro represents a critical safety advantage. Because tirzepatide only stimulates insulin release when blood glucose is elevated, hypoglycaemia rates remain low — just 0.6% in the SURPASS-3 trial compared to 7.3% with insulin degludec [4]. Insulin therapy, particularly with rapid-acting formulations, carries inherent hypoglycaemia risk regardless of glucose levels if dosing exceeds physiological requirements.

Weight Management: A Key Clinical Distinction

One of the most significant differences between mounjaro and insulin concerns weight outcomes. Insulin therapy is typically associated with weight gain, averaging 2-4kg in the first year of treatment, as improved glucose control allows previously wasted calories to be stored [2]. This weight gain often complicates type 2 diabetes management, as increased adiposity worsens insulin resistance.

Mounjaro produces the opposite effect. In the SURMOUNT-1 trial, participants without diabetes achieved an average body weight reduction of 22.5% over 72 weeks on the 15mg dose — the highest weight loss recorded in any pharmacological obesity trial to date [5]. Even in diabetes populations, SURPASS trials demonstrated average weight reductions of 11-13kg, addressing both glycaemic control and the obesity that underpins most type 2 diabetes cases [3][4].

Appetite Regulation and Metabolic Effects

Mounjaro's weight loss mechanism extends beyond simple calorie restriction. GLP-1 receptor activation in hypothalamic regions reduces appetite and increases satiety, whilst delayed gastric emptying prolongs fullness after meals [1]. The additional GIP receptor agonism may enhance fat metabolism and energy expenditure, contributing to the superior weight outcomes observed in head-to-head trials against single-pathway GLP-1 agonists.

Feature Mounjaro (Tirzepatide) Insulin Therapy
Medication Type Dual GIP/GLP-1 receptor agonist Hormone replacement
Mechanism Enhances natural insulin secretion Directly replaces insulin
Dosing Frequency Once weekly injection 1-6 times daily (varies by regimen)
Hypoglycaemia Risk Very low (0.6%) Moderate to high (7-15%)
Weight Effect Average 11-13kg loss in diabetes trials Average 2-4kg gain
Suitable For Type 2 diabetes with retained pancreatic function Type 1 and advanced type 2 diabetes
Starting Price (UK) From £124.99 Available on NHS prescription

Clinical Indications: When Each Treatment Is Appropriate

Insulin remains the cornerstone treatment for type 1 diabetes, where autoimmune destruction of pancreatic beta cells leaves patients unable to produce any endogenous insulin. It's also essential for type 2 diabetes patients with severely impaired pancreatic function, those with contraindications to oral medications, and during acute illness or perioperative periods when tight glucose control is critical [2].

Mounjaro is licensed in the UK for adults with type 2 diabetes and inadequate glycaemic control on metformin or other first-line therapies, and for weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related comorbidities [1]. It's particularly valuable for patients where weight loss would provide dual benefits for diabetes control and cardiovascular risk reduction. All prescriptions require assessment by a UK prescriber to confirm suitability, as Mounjaro is not appropriate for type 1 diabetes, diabetic ketoacidosis, or severe renal impairment.

Administration and Treatment Burden Comparison

Insulin regimens vary considerably in complexity. Basal insulin requires once-daily injection, whilst basal-bolus regimens involve 4-6 daily injections timed around meals, with doses adjusted based on carbohydrate intake and blood glucose readings. This treatment burden, combined with the need for frequent glucose monitoring, can significantly impact quality of life and treatment adherence.

Mounjaro offers a simplified once-weekly subcutaneous injection using a pre-filled KwikPen device. Starting at 2.5mg for four weeks, the dose is typically titrated monthly up to 5mg, 7.5mg, 10mg, 12.5mg, or the maximum 15mg dose, based on glycaemic response and tolerability [1]. The extended dosing interval and lack of meal-timing requirements reduce treatment burden considerably compared to multi-dose insulin regimens.

UK Availability and Prescribing Pathway

At Cured Pharmacy, Mounjaro is available from £124.99 following a free online consultation with a UK-registered prescriber. Our clinical team assesses your medical history, current medications, and treatment goals to determine suitability. Unlike insulin, which is typically initiated and managed by diabetes specialist teams, Mounjaro can be prescribed through remote consultations with appropriate clinical oversight and safety monitoring.

Side Effect Profiles and Safety Considerations

Insulin's primary safety concern is hypoglycaemia, which can range from mild symptoms like tremor and sweating to severe neuroglycopenia requiring emergency treatment. Weight gain, injection site reactions, and rare allergic responses represent additional considerations. Patients require education on recognising and managing hypoglycaemia, along with regular blood glucose monitoring [2].

Mounjaro's most common side effects are gastrointestinal — nausea (12-22% of patients), diarrhoea (13-16%), vomiting (6-10%), and constipation (6-7%) [1]. These effects are typically mild to moderate, occur predominantly during dose escalation, and diminish over time. Serious side effects are rare but include pancreatitis risk (0.2% in trials), gallbladder disease, and potential thyroid C-cell tumours observed in rodent studies (though no human cases have been causally linked) [3]. The medication carries a black box warning in some jurisdictions regarding thyroid tumours, and is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Scientific References

  1. Electronic Medicines Compendium. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
  2. National Institute for Health and Care Excellence. (2022). Type 2 diabetes in adults: management (NG28). https://www.nice.org.uk/guidance/ng28 [accessed 13 August 2026]
  3. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
  4. Ludvik, B., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
  5. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is not suitable for type 1 diabetes or as a replacement for insulin in patients who require insulin therapy.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is Mounjaro a type of insulin?
No, Mounjaro is not insulin. It's a dual GIP/GLP-1 receptor agonist that stimulates your body's own insulin production in a glucose-dependent manner, rather than directly replacing insulin like injectable insulin therapy does.
Can Mounjaro replace insulin for type 2 diabetes?
In some cases, Mounjaro may reduce or eliminate insulin requirements for type 2 diabetes patients, but this decision must be made by your prescriber based on your pancreatic function, glycaemic control, and individual clinical circumstances.
Does Mounjaro vs insulin cause more weight loss?
Yes, clinical trials show Mounjaro produces significant weight loss (average 11-13kg in diabetes populations), whilst insulin therapy typically causes weight gain of 2-4kg in the first year.
What are the main mounjaro insulin comparison differences in side effects?
Insulin's primary risk is hypoglycaemia (7-15% incidence), whilst Mounjaro's main side effects are gastrointestinal symptoms like nausea and diarrhoea, with very low hypoglycaemia risk (0.6%).
Can I take Mounjaro if I'm already on insulin?
Mounjaro can be used alongside insulin in some cases, though this requires careful prescriber supervision and insulin dose adjustments to prevent hypoglycaemia. Your UK prescriber will assess whether combination therapy is appropriate for your situation.
How quickly does Mounjaro work compared to insulin?
Insulin acts within minutes to hours depending on formulation, whilst Mounjaro reaches steady-state concentrations after 4 weeks of weekly dosing. Glycaemic improvements with Mounjaro typically become apparent within 4-8 weeks.
Is Mounjaro suitable for type 1 diabetes like insulin?
No, Mounjaro is not licensed or appropriate for type 1 diabetes. It requires functioning pancreatic beta cells to work, which type 1 diabetes patients lack. Insulin replacement remains essential for all type 1 diabetes patients.
What is the difference between mounjaro and insulin in terms of UK cost?
Insulin is available on NHS prescription for diabetes patients, whilst Mounjaro for weight management typically requires private prescription. At Cured Pharmacy, Mounjaro starts from £124.99 following clinical assessment by a UK prescriber.
What are the main differences between Mounjaro and insulin in the UK?
Mounjaro is a GLP-1 receptor agonist that helps regulate blood sugar and promotes weight loss, while insulin directly replaces the hormone your body lacks. Mounjaro is typically used for type 2 diabetes and weight management, whereas insulin is essential for type 1 diabetes and advanced type 2 cases. Cured Pharmacy offers consultations to determine which treatment suits your needs.
Can I switch from insulin to Mounjaro for type 2 diabetes?
Switching from insulin to Mounjaro is possible for some people with type 2 diabetes, but it must be done under medical supervision. Your prescriber will assess your blood sugar control, overall health, and diabetes management goals before making any changes. Cured Pharmacy's UK-registered prescribers can review your case and guide you through the transition safely.
Is Mounjaro more expensive than insulin in the UK?
Mounjaro starts from £124.99 at Cured Pharmacy, while insulin costs vary depending on the type and dosage required. Many patients find Mounjaro offers better weight loss benefits alongside blood sugar control, which may provide additional value. Cured Pharmacy offers competitive pricing with £20 off your first order using code Weightlossnew.
Does Mounjaro work faster than insulin for lowering blood sugar?
Insulin works immediately to lower blood sugar levels, making it essential for acute management and type 1 diabetes. Mounjaro works more gradually over days to weeks, improving blood sugar control and promoting weight loss through appetite regulation. Both treatments serve different purposes, and Cured Pharmacy's prescribers can help determine the right approach for your diabetes management.
Can I use Mounjaro and insulin together for diabetes control?
Yes, some patients use Mounjaro alongside insulin when prescribed by their doctor, particularly if transitioning or managing complex type 2 diabetes. This combination requires careful monitoring to prevent low blood sugar and adjust dosages appropriately. Cured Pharmacy's UK-registered prescribers can assess whether combining treatments is suitable for your individual diabetes care plan.
What are the key differences between Mounjaro and insulin in the UK?
Mounjaro is a GLP-1 and GIP receptor agonist taken once weekly, while insulin is a hormone replacement typically taken multiple times daily. Mounjaro helps the body produce its own insulin and promotes weight loss, whereas insulin directly replaces what the pancreas cannot produce and may cause weight gain.
Can I switch from insulin to Mounjaro in the UK?
Switching from insulin to Mounjaro must be done under medical supervision through a UK-registered prescriber. Cured Pharmacy's clinical team will review your medical history, current insulin regimen, and HbA1c levels to determine if Mounjaro is a suitable alternative for your type 2 diabetes management.
Is Mounjaro more effective than insulin for type 2 diabetes in the UK?
Clinical studies show Mounjaro can be highly effective for type 2 diabetes, often achieving greater HbA1c reductions and weight loss compared to some insulin regimens. However, effectiveness depends on individual circumstances, and some patients may require insulin or combination therapy, which your Cured Pharmacy prescriber will assess.
Does the NHS cover Mounjaro or insulin for diabetes treatment?
The NHS provides insulin free on prescription for diabetes, while Mounjaro availability through the NHS is currently limited and subject to strict eligibility criteria. Cured Pharmacy offers private Mounjaro prescriptions from £124.99, making it accessible for those who don't meet NHS criteria or prefer faster access.
How do Mounjaro and insulin costs compare in the UK?
While NHS insulin prescriptions cost standard prescription charges, private Mounjaro through Cured Pharmacy starts at £124.99 per month with £20 off your first order using code Weightlossnew. The cost difference reflects Mounjaro's newer technology, weekly dosing convenience, and additional weight loss benefits compared to traditional insulin therapy.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.